Study on low sperm count by giving Kalnar Parpam Tablet

TO DETERMINE THE EFFECTIVENESS OF KALNAR PARPAM IN THE MANAGEMENT OF VINDHU NATTAM (OLIGOSPERMIA) AMONG OUTPATIENTS ATTENDING AYOTHIDOSS PANDITHAR HOSPITAL, NATIONAL INSTITUTE OF SIDDHA – A PILOT STUDY - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058832

Enrollment

Registered

2023-10-18

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N461- Oligospermia

Interventions

Intervention1: Kalnar Parpam Tablet: 2 Tablets twice a day with Ghee or Butter for 90 days Control Intervention1: NA: NA

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patient having abnormalities of Semen parameters Oligozoospermia (Sperm count 2. Poor motility, poor quantity and quality of seminal fluid 3. Willing to sign the consent form for enrollment in the study.

Exclusion criteria

Exclusion criteria: 1. Azoospermia 2. K/C/O testicular varicocele and hydrocele 3. K/C/O Filiariasis 4. History of Undescended testis 5. Genetic issues 6. Patients having chronic illness or tumors • Any anatomical defects

Design outcomes

Primary

Measure	Time frame
Improvement in semen parameters such as sperm count, volume, viscosity both in quality and quantity, morphology will be assessed by semen analysisTimepoint: 90 days	—

Secondary

Measure	Time frame
NATimepoint: NA	—

Countries

India

Contacts

Public ContactDr S LALITHAKUMARI

National Institute of Siddha

christianvijila@gmail.com9962545930

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026